APA

Géraud A., Xu H. P., Beuzeboc P. & Kirova Y. M. (20170213). Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. : Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Chicago

Géraud A, Xu H P, Beuzeboc P and Kirova Y M. 20170213. Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. : Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Harvard

Géraud A., Xu H. P., Beuzeboc P. and Kirova Y. M. (20170213). Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. : Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

MLA

Géraud A, Xu H P, Beuzeboc P and Kirova Y M. Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. : Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 20170213.